Titre : Transplantation de main

Transplantation de main : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Transplantation de main : Questions médicales les plus fréquentes", "headline": "Transplantation de main : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Transplantation de main : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-21", "dateModified": "2026-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Transplantation de main" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Allotransplantation composite vascularisée", "url": "https://questionsmedicales.fr/mesh/D063986", "about": { "@type": "MedicalCondition", "name": "Allotransplantation composite vascularisée", "code": { "@type": "MedicalCode", "code": "D063986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E04.936.864.850" } } }, "about": { "@type": "MedicalCondition", "name": "Transplantation de main", "alternateName": "Hand Transplantation", "code": { "@type": "MedicalCode", "code": "D063987", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Simon G Talbot", "url": "https://questionsmedicales.fr/author/Simon%20G%20Talbot", "affiliation": { "@type": "Organization", "name": "Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA." } }, { "@type": "Person", "name": "Linda C Cendales", "url": "https://questionsmedicales.fr/author/Linda%20C%20Cendales", "affiliation": { "@type": "Organization", "name": "Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA." } }, { "@type": "Person", "name": "L Scott Levin", "url": "https://questionsmedicales.fr/author/L%20Scott%20Levin", "affiliation": { "@type": "Organization", "name": "Department of Orthopaedic Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA; Division of Plastic and Reconstructive Surgery, The Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104, USA; Department of Orthopaedic Surgery, The Children's Hospital of Philadelphia, PA 19104, USA." } }, { "@type": "Person", "name": "Bohdan Pomahac", "url": "https://questionsmedicales.fr/author/Bohdan%20Pomahac", "affiliation": { "@type": "Organization", "name": "Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA." } }, { "@type": "Person", "name": "Simon P J Kay", "url": "https://questionsmedicales.fr/author/Simon%20P%20J%20Kay", "affiliation": { "@type": "Organization", "name": "Department of Plastic and Reconstructive Surgery, Leeds Teaching Hospitals, Leeds, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The presence of busulfan metabolites and pharmacometabolomics in plasma drawn immediately before allograft infusion in hematopoietic cell transplant recipients.", "datePublished": "2023-10-10", "url": "https://questionsmedicales.fr/article/37749994", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cts.13651" } }, { "@type": "ScholarlyArticle", "name": "Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin.", "datePublished": "2023-10-09", "url": "https://questionsmedicales.fr/article/37801553", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/LVT.0000000000000277" } }, { "@type": "ScholarlyArticle", "name": "Use of Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Cardiac Transplantation: Results of an A Priori Ventless Approach.", "datePublished": "2023-10-06", "url": "https://questionsmedicales.fr/article/37797341", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MAT.0000000000002051" } }, { "@type": "ScholarlyArticle", "name": "Implementing a self-reported immunosuppression adherence questionnaire to screen for non-adherence in routine care of kidney transplant recipients.", "datePublished": "2023-10-04", "url": "https://questionsmedicales.fr/article/37792310", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ctr.15157" } }, { "@type": "ScholarlyArticle", "name": "Acute myeloid leukaemia relapse after allogeneic haematopoietic stem cell transplantation: Mechanistic diversity and therapeutic directions.", "datePublished": "2023-10-03", "url": "https://questionsmedicales.fr/article/37787151", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/bjh.19121" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Procédures de chirurgie opératoire", "item": "https://questionsmedicales.fr/mesh/D013514" }, { "@type": "ListItem", "position": 3, "name": "Transplantation", "item": "https://questionsmedicales.fr/mesh/D014180" }, { "@type": "ListItem", "position": 4, "name": "Transplantation homologue", "item": "https://questionsmedicales.fr/mesh/D014184" }, { "@type": "ListItem", "position": 5, "name": "Allotransplantation composite vascularisée", "item": "https://questionsmedicales.fr/mesh/D063986" }, { "@type": "ListItem", "position": 6, "name": "Transplantation de main", "item": "https://questionsmedicales.fr/mesh/D063987" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Transplantation de main - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Transplantation de main", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-04-29", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Transplantation de main", "description": "Comment évaluer la nécessité d'une transplantation de main ?\nQuels tests sont nécessaires avant la transplantation ?\nQui est un bon candidat pour cette chirurgie ?\nComment déterminer la compatibilité du donneur ?\nQuels critères excluent une transplantation de main ?", "url": "https://questionsmedicales.fr/mesh/D063987?page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Transplantation de main", "description": "Quels symptômes indiquent un besoin de transplantation ?\nComment se manifeste le rejet du greffon ?\nQuels signes d'infection doivent alerter ?\nQuels symptômes psychologiques peuvent survenir ?\nComment évaluer la fonction de la main greffée ?", "url": "https://questionsmedicales.fr/mesh/D063987?page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Transplantation de main", "description": "Comment prévenir le rejet du greffon ?\nQuelles mesures d'hygiène sont recommandées ?\nComment éviter les complications post-opératoires ?\nQuels conseils pour une bonne récupération ?\nComment gérer le stress lié à la transplantation ?", "url": "https://questionsmedicales.fr/mesh/D063987?page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Transplantation de main", "description": "Quel est le processus de la transplantation de main ?\nQuels médicaments sont prescrits après la greffe ?\nQuelle est la durée de l'hospitalisation après la greffe ?\nQuelles thérapies sont recommandées après la greffe ?\nComment se déroule le suivi post-opératoire ?", "url": "https://questionsmedicales.fr/mesh/D063987?page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Transplantation de main", "description": "Quelles sont les complications possibles après la greffe ?\nComment reconnaître une infection après la greffe ?\nQuels sont les risques de rejet aigu ?\nComment traiter une infection post-greffe ?\nQuelles sont les conséquences d'un rejet chronique ?", "url": "https://questionsmedicales.fr/mesh/D063987?page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Transplantation de main", "description": "Quels facteurs augmentent le risque de rejet ?\nComment l'âge influence-t-il le succès de la greffe ?\nQuels comportements augmentent le risque d'infection ?\nComment le statut immunitaire affecte-t-il la greffe ?\nQuels antécédents médicaux sont préoccupants ?", "url": "https://questionsmedicales.fr/mesh/D063987?page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la nécessité d'une transplantation de main ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation inclut l'examen clinique, l'imagerie et l'analyse des antécédents médicaux." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant la transplantation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins, des examens d'imagerie et des évaluations psychologiques sont requis." } }, { "@type": "Question", "name": "Qui est un bon candidat pour cette chirurgie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les candidats doivent être en bonne santé générale et avoir des attentes réalistes." } }, { "@type": "Question", "name": "Comment déterminer la compatibilité du donneur ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La compatibilité est évaluée par des tests immunologiques et des analyses de tissus." } }, { "@type": "Question", "name": "Quels critères excluent une transplantation de main ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies graves, des infections actives ou des troubles psychologiques peuvent exclure." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin de transplantation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "La perte de fonction, la douleur chronique et l'absence de régénération sont des indicateurs." } }, { "@type": "Question", "name": "Comment se manifeste le rejet du greffon ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le rejet peut se manifester par une rougeur, un gonflement et une douleur au site de greffe." } }, { "@type": "Question", "name": "Quels signes d'infection doivent alerter ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une fièvre, des frissons, ou un écoulement purulent au site de greffe sont préoccupants." } }, { "@type": "Question", "name": "Quels symptômes psychologiques peuvent survenir ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de l'humeur, de l'anxiété ou des difficultés d'adaptation peuvent apparaître." } }, { "@type": "Question", "name": "Comment évaluer la fonction de la main greffée ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de force, de dextérité et d'amplitude de mouvement sont utilisés pour évaluer." } }, { "@type": "Question", "name": "Comment prévenir le rejet du greffon ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le respect du traitement immunosuppresseur et des suivis réguliers est crucial." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène des mains et éviter les infections est essentiel." } }, { "@type": "Question", "name": "Comment éviter les complications post-opératoires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical rigoureux et une rééducation précoce aident à prévenir les complications." } }, { "@type": "Question", "name": "Quels conseils pour une bonne récupération ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les recommandations médicales, faire de l'exercice et éviter le stress sont conseillés." } }, { "@type": "Question", "name": "Comment gérer le stress lié à la transplantation ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des séances de soutien psychologique et des groupes de parole peuvent aider à gérer le stress." } }, { "@type": "Question", "name": "Quel est le processus de la transplantation de main ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie implique la connexion des os, des nerfs, des vaisseaux sanguins et des muscles." } }, { "@type": "Question", "name": "Quels médicaments sont prescrits après la greffe ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des immunosuppresseurs sont nécessaires pour prévenir le rejet du greffon." } }, { "@type": "Question", "name": "Quelle est la durée de l'hospitalisation après la greffe ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation dure généralement de 1 à 2 semaines, selon la récupération." } }, { "@type": "Question", "name": "Quelles thérapies sont recommandées après la greffe ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation fonctionnelle et la thérapie occupationnelle sont essentielles pour la récupération." } }, { "@type": "Question", "name": "Comment se déroule le suivi post-opératoire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le suivi inclut des consultations régulières pour surveiller la fonction et le rejet." } }, { "@type": "Question", "name": "Quelles sont les complications possibles après la greffe ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le rejet, les infections et les problèmes vasculaires." } }, { "@type": "Question", "name": "Comment reconnaître une infection après la greffe ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une rougeur, un gonflement, de la chaleur et de la douleur au site de greffe peuvent indiquer une infection." } }, { "@type": "Question", "name": "Quels sont les risques de rejet aigu ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le rejet aigu peut survenir dans les premières semaines après la transplantation." } }, { "@type": "Question", "name": "Comment traiter une infection post-greffe ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement implique des antibiotiques et un suivi médical étroit." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'un rejet chronique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le rejet chronique peut entraîner une perte de fonction progressive du greffon." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de rejet ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de rejet, l'incompatibilité tissulaire et le non-respect du traitement augmentent le risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le succès de la greffe ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les patients plus jeunes ont généralement de meilleures chances de succès que les plus âgés." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'alcoolisme et une mauvaise hygiène augmentent le risque d'infection." } }, { "@type": "Question", "name": "Comment le statut immunitaire affecte-t-il la greffe ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un statut immunitaire affaibli augmente le risque de rejet et d'infection post-greffe." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont préoccupants ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de maladies auto-immunes ou de cancers peuvent compliquer la greffe." } } ] } ] }

Sources (10000 au total)

Implementing a self-reported immunosuppression adherence questionnaire to screen for non-adherence in routine care of kidney transplant recipients.

Self-reported measures of immunosuppression adherence have been largely examined in research settings.... In this single center study of 610 kidney transplant recipients, we examined if a voluntary, non-anonymous self-report measure could identify non-adherence in a routine clinic setting and how patients... Non-responders to the survey (15%) were younger, more likely to be black, and less likely to have had a pre-emptive transplant. Among complete responders (n = 485), 38% reported non-adherence with non... In summary, a self-reported questionnaire during clinic visits identified immunosuppression non-adherence in a significant proportion of patients and was well received by patients. Integrating self-re...

Acute myeloid leukaemia relapse after allogeneic haematopoietic stem cell transplantation: Mechanistic diversity and therapeutic directions.

Emerging biological and clinical data, along with advances in new technologies, have exposed the mechanistic diversity in post-haematopoietic stem cell transplant (HCT) relapse. Post-HCT relapse mecha...

Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol.

Short-term outcomes using steroid avoidance immune suppression are encouraging in pediatric heart transplant (HT) recipients at low risk of antibody-mediated rejection. We assessed medium-term outcome... All primary HT recipients during 2006-2020 who did not have a donor-specific antibody were eligible for immune suppression consisting of 5-d Thymoglobulin/steroid induction followed by a tacrolimus-ba... Overall, 150 of 181 primary HT recipients were eligible for steroid avoidance regimen. Their median age was 8.7 y, 41% had congenital heart disease, 23% were sensitized, and 35% were on a mechanical s... Pediatric HT recipients at low risk of antibody-mediated rejection have excellent medium-term survival and relatively low incidence of posttransplant morbidities when managed using a steroid avoidance...

The Role of Mechanical Thrombectomy for Acute Massive Pulmonary Embolism in a Patient With Unilateral Lung Transplant and Atrial Septal Defect.

The risk of thromboembolic disease is high in patients with lung transplantation and is associated with significant morbidity and mortality with single healthy transplanted lung. We present a case inv... A 65-year-old man with a history of interstitial lung disease status post single left orthotopic lung transplant in 2012 presented with acute massive PE and clot burden in the pulmonary arteries of th... Endovascular mechanical thrombectomy was safely used to treat acute massive PE in a single transplanted lung in the presence of ASD.... Endovascular mechanical thrombectomy could be safely utilized to treat patients with lung transplant and acute massive or submassive pulmonary embolism. However, safely of mechanical thrombectomy shou...